CERo Therapeutics Holdings (CERO) announces the appointment of Eric Francois to the Company’s Board of Directors. Formerly, he served as CFO of SCYNEXIS (SCYX).
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CERO:
- CERo Therapeutics Announces Convertible Note Financing and New Director
- Cero Therapeutics to present data from Phase 2 trial of CER-1236
- CERo Therapeutics Securities Delisted Following Nasdaq Appeal Denial
- CERo Therapeutics reports encouraging early CERTAINT-1 trial data
- Cero Therapeutics provides update on Phase 1 trial of CER-1236